News
-
Vit D controversy
Tuesday | Oct 16 2018VITAMIN D supplementation may be worthwhile in spite of a recent meta-analysis, according to Professor Rebecca Mason, professor of endocrine physiology at the University of Sydney.
-
Migraine burden
Tuesday | Oct 16 2018MIGRAINE headaches cost the Australian economy almost $36 billion annually, according to a new report prepared for Novartis Australia which will be released today in Canberra.
-
Pharmtechs have GRIT
Tuesday | Oct 16 2018TODAY the pharmacy community celebrates Pharmacy Technician Day and to mark the occasion, the Society of Hospital Pharmacists of Australia (SHPA) is including in its official magazine Pharmacy GRIT an article about an advanced scope pharmacy assistant role.
-
2019 flu vax makeup
Tuesday | Oct 16 2018THE Australian Influenza Vaccine Committee has issued its recommendations for viruses to be included in influenza vaccines in the 2019 southern hemisphere influenza season.
-
Lifespot vaporiser
Tuesday | Oct 16 2018ASX-LISTED Lifespot Health has launched a new inhaler product for medical cannabis which allows users to monitor their use via integrated software.
-
Idaho prescribing
Tuesday | Oct 16 2018PHARMACISTS in the US state of Idaho have been authorised to prescribe more than 20 categories of medication, with new regulations being phased in covering cold sores, motion sickness prevention and uncomplicated urinary tract infections.
-
Leukaemia cure?
Tuesday | Oct 16 2018A REVOLUTIONARY new treatment that has the potential to cure leukaemia might soon be available in Australia's public hospitals, according to the Minister for Health Greg Hunt.
-
Novotech purchase
Tuesday | Oct 16 2018CONTRACT research organisation Novotech has purchased Clinical Network Services (CNS), giving it an expanded presence across Australia and New Zealand as well as the US.
-
BMS appointment
Tuesday | Oct 16 2018NEIL MacGregor has been named as the new head of Bristol-Myers Squibb for Australia and NZ.
-
UK, India fake meds collaboration
Tuesday | Oct 16 2018BRITAIN'S Medicines and Healthcare products Regulatory Agency (MHRA) will work together with India's Directorate of Revenue Intelligence (DRI) to target regions suspected of sending unlicensed medicines into the UK.
